An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Uludag University, Bursa, Turkey
Turku PET Centre, Turku, Finland
Department of Anesthesiology,Guangzhou Military Region General Hospital, Guangzhou, Guangdong, China
Assiut university hospitals, Assiut, Assiut governorate, Egypt
Department of Anesthesiology and Pain Medicine, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
WVU Healthcare Ruby Memorial Hospital, Morgantown, West Virginia, United States
Sir Ganga Ram Hospital, New Delhi, India
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Medical University of Gdansk, Gdansk, Poland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.